Tufton Capital Management’s Blonder Tongue Laboratories Inc BDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-188,940
| Closed | -$120K | – | 125 |
|
|
2022
Q1 | $120K | Hold |
188,940
| – | – | 0.02% | 125 |
|
|
2021
Q4 | $111K | Hold |
188,940
| – | – | 0.02% | 131 |
|
|
2021
Q3 | $215K | Hold |
188,940
| – | – | 0.04% | 122 |
|
|
2021
Q2 | $249K | Hold |
188,940
| – | – | 0.04% | 116 |
|
|
2021
Q1 | $277K | Buy |
+188,940
| New | +$297K | 0.05% | 110 |
|
|
2017
Q2 | – | Sell |
-158,940
| Closed | -$92K | – | 127 |
|
|
2017
Q1 | $92K | Hold |
158,940
| – | – | 0.02% | 120 |
|
|
2016
Q4 | $75K | Hold |
158,940
| – | – | 0.02% | 104 |
|
|
2016
Q3 | $98K | Buy |
158,940
+40,000
| +34% | +$23.1K | 0.02% | 101 |
|
|
2016
Q2 | $57K | Buy |
+118,940
| New | +$48.4K | 0.01% | 98 |
|
|
2016
Q1 | – | Sell |
-118,940
| Closed | -$48K | – | 104 |
|
|
2015
Q4 | $48K | Hold |
118,940
| – | – | 0.01% | 95 |
|
|
2015
Q3 | $77K | Hold |
118,940
| – | – | 0.02% | 95 |
|
|
2015
Q2 | $92K | Buy |
118,940
+60,000
| +102% | +$47.3K | 0.02% | 99 |
|
|
2015
Q1 | $57K | Hold |
58,940
| – | – | 0.01% | 112 |
|
|
2014
Q4 | $159K | Hold |
58,940
| – | – | 0.03% | 113 |
|
|
2014
Q3 | $78K | Hold |
58,940
| – | – | 0.01% | 114 |
|
|
2014
Q2 | $54K | Buy |
+58,940
| New | +$54.3K | 0.01% | 115 |
|
|
2013
Q3 | – | Sell |
-58,940
| Closed | -$62K | – | 120 |
|
|
2013
Q2 | $62K | Buy |
+58,940
| New | +$61.4K | 0.01% | 109 |
|
Tufton Capital Management's BDR Position: Q2 2022 in Review
Tufton Capital Management sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2022, closing a stake of 188,940 shares — an estimated $120K sold.
Tufton Capital Management first reported a position in BDR in Q2 2013 and held it in 17 quarters. The position peaked at $277K in Q1 2021. 0 funds tracked by Wall St. Rank hold BDR as of Q2 2022.
- Tufton Capital Management reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2022 after selling out during the quarter.
- Tufton Capital Management sold 188,940 Blonder Tongue Laboratories Inc shares in Q2 2022, an estimated $120K.
- Tufton Capital Management first reported a position in Blonder Tongue Laboratories Inc in Q2 2013 and held it in 17 quarters.
- Tufton Capital Management's Blonder Tongue Laboratories Inc position peaked at $277K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2022.
Based on Tufton Capital Management's 13F filing for Q2 2022, filed 20 Jul 2022.